The story in detail
Familial melanoma genes are often studied in families selected because of cancer history. This analysis instead began with almost 697,000 people in two genomic databases and linked their results to cancer records. It examined pathogenic variants across eight genes or regions. Such variants were uncommon overall but more frequent among people with multiple melanomas or an early diagnosis.
Starting with population cohorts can complement risk estimates from highly selected families. However, most participants had European ancestry, limiting transfer to other populations. Carrying a variant does not make cancer inevitable, and newly observed associations need further scrutiny. The findings may inform genetic counselling and testing criteria; they do not, by themselves, justify offering identical genetic screening to everyone.
Study date: 2026-05-27 · Story: 20 October 2026
What was found?
Researchers examined eight familial melanoma genes in nearly 697,000 people across two datasets. Disease-associated variants exceeded a 2.5% prevalence threshold among people with multiple melanomas or a first melanoma before age 40.
What does it mean?
This pattern supports considering a broader group of patients for genetic counselling to explore inherited susceptibility alongside the existing cancer.
Limitations
Most participants had European ancestry, limiting generalizability. These observational results do not recommend universal testing; personal and family history remain important when deciding whether genetic assessment is appropriate.
Sources and review scope
Original article (DOI) · Reviewed source 1
The original research abstract was reviewed.
Sources last checked: 20 October 2026.
Editorial expansion: 21.10.2026
Keep this story
Feedback to the editor
Only the editor can read this; it is not a public comment. Do not include personal health information.
Sign in to send feedback